IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $927,204 | -10.8% | 20,441 | -13.1% | 0.00% | 0.0% |
Q3 2022 | $1,040,000 | -11.3% | 23,517 | -20.0% | 0.00% | -33.3% |
Q2 2021 | $1,172,000 | +332.5% | 29,382 | +512.1% | 0.00% | +200.0% |
Q4 2020 | $271,000 | -50.5% | 4,800 | -48.4% | 0.00% | -50.0% |
Q2 2020 | $548,000 | +17.1% | 9,300 | -6.0% | 0.00% | 0.0% |
Q1 2020 | $468,000 | +2240.0% | 9,895 | +2889.4% | 0.00% | – |
Q4 2019 | $20,000 | -37.5% | 331 | -38.5% | 0.00% | – |
Q3 2019 | $32,000 | -98.6% | 538 | -98.5% | 0.00% | -100.0% |
Q2 2019 | $2,246,000 | -84.9% | 34,939 | -81.0% | 0.01% | -85.7% |
Q1 2019 | $14,919,000 | -22.0% | 183,800 | -48.1% | 0.08% | -35.3% |
Q4 2018 | $19,138,000 | +71.6% | 354,023 | +63.7% | 0.12% | +58.7% |
Q3 2018 | $11,152,000 | -0.7% | 216,202 | -19.8% | 0.08% | +8.7% |
Q2 2018 | $11,229,000 | +9.0% | 269,474 | +15.3% | 0.07% | -15.9% |
Q1 2018 | $10,306,000 | -13.1% | 233,800 | -0.8% | 0.08% | -6.8% |
Q4 2017 | $11,861,000 | +52.2% | 235,800 | +53.4% | 0.09% | +41.9% |
Q3 2017 | $7,793,000 | – | 153,700 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |